COLORADO STATE: CLINICAL TRIAL FOR TRANSDERMAL MIRTAZAPINE IN CATS
Mirtazapine is a medication that has been used in human medicine as an antidepressant. The drug widely used in veterinary medicine due to the presence of several desirable effects, namely its significant anti-nausea, anti-vomiting and appetite stimulating properties. It has been shown to be effective in increasing weight and appetite and decreasing vomiting in cats with chronic kidney disease. However, many owners have difficulty administering pills to their cat. We believe that mirtazapine, like many other medications, could be effective when formulated as a transdermal gel that can be applied to the skin of the ear. The purpose of this study is to perform a study to document the appetite stimulation properties of the transdermal form of the drug in cats with kidney disease.
Download the client consent form and learn more about this clinical trial.